注意缺陷多动障碍儿童接受兴奋剂治疗后的性别特异性长期身高与体质指数轨迹
这项回顾性队列研究基于以色列Clalit健康服务数据库,纳入4561例5-18岁接受兴奋剂治疗的ADHD患儿,评估性别特异的身高z值和BMI z值轨迹。研究发现男孩身高z值下降幅度(约0.2 SD)大于女孩(约0.06 SD),且男孩在1年和≥2年后持续下降,女孩1年后下降后稳定;BMI z值轨迹两性相似,1年后下降更明显,≥2年后回升。非ADHD对照组在治疗1年后身高z值和BMI z值均高于ADHD组(P < .001)。
要点
- 男孩身高z值下降约0.2 SD,女孩约0.06 SD,男孩下降更明显且持续。
- BMI z值轨迹两性相似,1年后下降更明显,≥2年后回升。
- 起始年龄小、依从性好、疗程长、社会经济地位低与生长抑制更明显相关。
核心结论
- 接受兴奋剂治疗的ADHD患儿中,男孩身高z值下降幅度大于女孩,且男孩在≥2年后仍持续下降。
- BMI z值轨迹两性相似,1年后下降更明显,≥2年后回升。
- 非ADHD对照组在治疗1年后身高z值和BMI z值均高于ADHD组(P < .001)。
研究设计与样本
- 回顾性队列研究,使用以色列Clalit健康服务数据库。
- 纳入5-18岁、有至少2次连续兴奋剂处方记录的ADHD患者共4561例(66%男孩)。
- 其中2151例(70%男孩)有≥2年治疗随访数据;另设性别和年龄匹配的非ADHD对照组4561例(66%男孩)。
主要发现
- 10.1%的队列身高z值下降≥1 SD,13.2%的队列BMI z值下降≥1 SD。
- 男孩身高z值下降约0.2 SD,女孩约0.06 SD。
- 男孩身高z值在1年和≥2年后持续下降,女孩身高z值1年后下降后稳定。
- BMI z值轨迹两性相似,1年后下降更明显,≥2年后回升。
- 起始年龄小、依从性好、疗程长、社会经济地位低与生长抑制更明显相关。
关键数值与推荐
- 身高z值下降≥1 SD见于10.1%的队列,BMI z值下降≥1 SD见于13.2%的队列。
- 男孩身高z值下降约0.2 SD,女孩约0.06 SD。
- 非ADHD对照组在治疗1年后身高z值和BMI z值均高于ADHD组(P < .001)。
临床怎么用
- 对接受兴奋剂治疗的ADHD患儿应进行生长监测,并配合饮食咨询。
- 男孩和起始年龄小、依从性好、疗程长、社会经济地位低的患儿可能更需要关注生长抑制。
局限性
- 本研究为回顾性队列研究,可能存在未测量的混杂因素。
- 随访≥2年的数据仅来自部分参与者(2151例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the sex-specific effects of stimulants in children with attention-deficit/hyperactivity disorder (ADHD) on body mass index (BMI) z and height z trajectories. STUDY DESIGN: A retrospective cohort study using the database of Israel Clalit Health Services was performed. Participants included 5- to 18-year-old insured patients with documentation of at least 2 consecutive prescriptions of stimulant drugs for ADHD. Participants were further compared with sex- and age-matched insured control patients without ADHD. RESULTS: A total of 4561 (66% boys) participants with ADHD were included. Of these, 2151 (70% boys) had follow-up data for ≥2 years of treatment. A decline of ≥1 SD in height and BMI z score was observed in 10.1% and 13.2% of the cohort, respectively. During ≥2 years follow-up, boys had a greater decline in height z score (~0.2 SD) than girls (~0.06 SD). Boys' height z score continued to decline after 1 and ≥2 years, and girls' height z score declined after 1 year, and then stabilized. The trajectory of BMI z score of boys and girls was similar, showing a greater decline after 1 year, followed by an incline after ≥2 years. Younger age at stimulants initiation, better adherence, longer treatment duration, and lower socioeconomic status were correlated with a greater impact on growth attenuation. The non-ADHD group (n = 4561, 66% boys) had baseline height z score and BMI z score similar to those in children with ADHD before treatment initiation. Height z score and BMI z score were greater in children without ADHD compared with children with ADHD following 1 year of treatment (P < .001). CONCLUSIONS: These findings highlight the importance of growth monitoring accompanied with dietary counseling in children with ADHD treated with stimulants.
引用
- Yackobovitch-Gavan M, Mimouni-Bloch A, Gabbay U, et al. Sex-Specific Long-Term Height and Body Mass Index Trajectories of Children Diagnosed with Attention-Deficit/Hyperactivity Disorder and Treated with Stimulants. J Pediatr. 2021. PMID: 34293373. doi:10.1016/j.jpeds.2021.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。